Why the study?
Reported prevalence of COVID-19-related myocardial involvement varies widely due to differing populations, imaging timing, and non-standardized CMR methodologies.
This SCMR consensus document provides standardized recommendations for CMR image acquisition, analysis, and reporting to evaluate cardiac involvement in patients with COVID-19.
Answers are grounded in this paper and cite their sources.
SCMR consensus CMR protocols should now guide cardiac evaluation in COVID-19; extends prior studies by enabling uniform multicenter data acquisition and reporting.
Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has affected nearly 600 million people to date across the world. While COVID-19 is primarily a respiratory illness, cardiac injury is also known to occur. Cardiovascular magnetic resonance (CMR) imaging is uniquely capable of characterizing myocardial tissue properties in-vivo, enabling insights into the pattern and degree of cardiac injury. The reported prevalence of myocardial involvement identified by CMR in the context of COVID-19 infection among previously hospitalized patients ranges from 26 to 60%. Variations in the reported prevalence of myocardial involvement may result from differing patient populations (e.g. differences in severity of illness) and the varying intervals between acute infection and CMR evaluation. Standardized methodologies in image acquisition, analysis, interpretation, and reporting of CMR abnormalities across would likely improve concordance between studies. This consensus document by the Society for Cardiovascular Magnetic Resonance (SCMR) provides recommendations on CMR imaging and reporting metrics towards the goal of improved standardization and uniform data acquisition and analytic approaches when performing CMR in patients with COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: